Page last updated: 2024-08-23

paclitaxel and Aortic Diseases

paclitaxel has been researched along with Aortic Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carvalho, PO; Gomes, FLT; Hatab, SA; Higuchi, ML; Kalil-Filho, R; Maranhão, RC; Mattos, FR; Pitta, FG; Serrano, CV; Tavares, ER	1
Ahn, Y; Cho, HH; Hong, MH; Jeong, HY; Jeong, MH; Kang, WS; Kee, HJ; Kim, YS; Kwon, JS	1
Deus, DF; Maranhão, RC; Morikawa, AT; Paladino-Filho, AT; Pinto, IM; Senra, T; Shiozaki, AA	1

Trials

1 trial(s) available for paclitaxel and Aortic Diseases

Article	Year
Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles. Clinics (Sao Paulo, Brazil), 2016, Volume: 71, Issue:8 Topics: Aged; Aged, 80 and over; Angiography; Aorta, Thoracic; Aortic Diseases; Atherosclerosis; Cholesterol; Drug Delivery Systems; Fat Emulsions, Intravenous; Female; Humans; Male; Multidetector Computed Tomography; Nanoparticles; Paclitaxel; Reproducibility of Results; Time Factors; Treatment Outcome; Triglycerides; Tubulin Modulators	2016

Article

Year

Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles.

Clinics (Sao Paulo, Brazil), 2016, Volume: 71, Issue:8

Topics: Aged; Aged, 80 and over; Angiography; Aorta, Thoracic; Aortic Diseases; Atherosclerosis; Cholesterol; Drug Delivery Systems; Fat Emulsions, Intravenous; Female; Humans; Male; Multidetector Computed Tomography; Nanoparticles; Paclitaxel; Reproducibility of Results; Time Factors; Treatment Outcome; Triglycerides; Tubulin Modulators

2016

Other Studies

2 other study(ies) available for paclitaxel and Aortic Diseases

Article	Year
Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles. Journal of cardiovascular pharmacology and therapeutics, 2018, Volume: 23, Issue:6 Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Cardiovascular Agents; Cholesterol, Dietary; Cytokines; Disease Models, Animal; Drug Compounding; Drug Therapy, Combination; Inflammation Mediators; Lipids; Liposomes; Male; Matrix Metalloproteinase 9; Methotrexate; Nanoparticles; Paclitaxel; Plaque, Atherosclerotic; Rabbits	2018
Cilostazol protects vessels against hyperglycemic injury and accelerates healing after implantation of drug-eluting stent in a type 1 diabetes mellitus rat aorta stent model. Atherosclerosis, 2013, Volume: 228, Issue:2 Topics: Administration, Oral; Angioplasty, Balloon; Animals; Aorta; Aortic Diseases; Apoptosis; Blood Glucose; Cilostazol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Drug-Eluting Stents; Endothelial Cells; Intercellular Adhesion Molecule-1; Male; Neovascularization, Pathologic; Paclitaxel; Phosphodiesterase 3 Inhibitors; Prosthesis Design; Rats; Rats, Sprague-Dawley; Tetrazoles; Thrombosis; Time Factors; Vascular Cell Adhesion Molecule-1; von Willebrand Factor; Wound Healing	2013

Article

Year

Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles.

Journal of cardiovascular pharmacology and therapeutics, 2018, Volume: 23, Issue:6

Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Cardiovascular Agents; Cholesterol, Dietary; Cytokines; Disease Models, Animal; Drug Compounding; Drug Therapy, Combination; Inflammation Mediators; Lipids; Liposomes; Male; Matrix Metalloproteinase 9; Methotrexate; Nanoparticles; Paclitaxel; Plaque, Atherosclerotic; Rabbits

2018

Cilostazol protects vessels against hyperglycemic injury and accelerates healing after implantation of drug-eluting stent in a type 1 diabetes mellitus rat aorta stent model.

Atherosclerosis, 2013, Volume: 228, Issue:2

Topics: Administration, Oral; Angioplasty, Balloon; Animals; Aorta; Aortic Diseases; Apoptosis; Blood Glucose; Cilostazol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Drug-Eluting Stents; Endothelial Cells; Intercellular Adhesion Molecule-1; Male; Neovascularization, Pathologic; Paclitaxel; Phosphodiesterase 3 Inhibitors; Prosthesis Design; Rats; Rats, Sprague-Dawley; Tetrazoles; Thrombosis; Time Factors; Vascular Cell Adhesion Molecule-1; von Willebrand Factor; Wound Healing

2013